PIEPER STEVEN (Chief Financial Officer) purchased 2.4% of their position (28K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $54.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2023ACC: 0001867096-23-000149
Officer· Chief Financial Officer
Since Oct 2021
+28K
Net shares
Net buyer
$54.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
28K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28K
Price / share
$1.95
Trade value
$54.60K
% of position
2.4%
11/20/2023
1.15M→1.18M
Total
Net shares
+28K
Net value
$54.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | P · Purchase | +28K | $1.95 | $54.60K | 2.4% | 1.15M | 1.18M |
| Total | +28K | $54.60K | ||||||
Derivative Transactions0
No derivative transactions reported